Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study

Tissue-type plasminogen activator (TPA) and plasminogen activator inhibitor-1 (PAI-1) have been shown to be associated with increased risk for stroke, however, the association with incident atrial fibrillation (AF) is unknown.

Source: International Journal of Cardiology - August 10, 2018 Category: Cardiology Authors: Bart A. Mulder, Bastiaan Geelhoed, Pim van der Harst, Henri M. Spronk, Isabelle C. Van Gelder, Folkert W. Asselbergs, Michiel Rienstra Tags: Short communication Source Type: research